Search
 
1    2    3    4   
Press Releases
Oct 15, 2015
Generex Announces Memorandum of Understanding in respect of a Phase II Clinical Trial for the Antigen Express Prostate Cancer Vaccine
Oct 13, 2015
Generex Announces Agreement to Acquire Equity Interest in MediTemp Ltd.
Oct 06, 2015
Generex Announces Agreement to Acquire Equity Interest in Alfa Rhythm Ltd.
All releases
Webcast Events and Media
 

Print Print     Email Email page

Investor Home


Investor Relations

For more information please contact:
Todd Falls
Tel: 1-800-391-6755
Fax: (647) 547-7104
Email: tfalls@generex.com


Exchange

OTC Bulletin Board

Listed Security

GNBT Common Stock

Transfer Agent

StockTrans, Inc.
44 West Lancaster Avenue
Ardmore, PA 19003
Phone 610-649-7300
Fax 610-649-7302

Corporate Counsel

Eckert Seamans Cherin & Mellott, LLC
1515 Market Street, 9th Floor
Philadelphia, PA 19102
Phone 215-851-8447
Fax 215-851-8383


Stock Quote
OTC BB: GNBT        0.01
10 Feb 2016    3:03 PM ET

Privacy Policy